Impaired Facial Emotion Recognition in Individuals at Ultra-High Risk for Psychosis and Associations With Schizotypy and Paranoia Level

Frontiers in Psychiatry
Eunchong SeoSuk Kyoon An

Abstract

Patients with schizophrenia and individuals at ultra-high risk for psychosis (UHR) have been reported to exhibit impaired recognition of facial emotion expressions. This impairment has involved both inaccuracy and negative bias of facial emotion recognition. The present study aimed to investigate whether UHR individuals display both types of impaired facial emotion recognition and to explore correlations between these impairments and schizotypy, as well as paranoia levels, in these individuals. A total of 43 UHR individuals and 57 healthy controls (HC) completed a facial emotion recognition task consisting of 60 standardized facial photographs. To explore correlations, we assessed schizotypy using the Revised Physical Anhedonia Scale and Magical Ideation Scale and paranoia level using the Paranoia Scale and persecution/suspicious item of the Positive and Negative Syndrome Scale in UHR individuals. Compared with HC, UHR individuals exhibited less accuracy for facial emotion recognition (70.6% vs. 75.6%, p=0.010) and a higher rate of "fear" responses for neutral faces (14.5% vs. 6.0%, p=0.003). In UHR individuals, inaccuracy was significantly correlated with schizotypy scores, but not with paranoia level. Conversely, "disgust" re...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1987·Schizophrenia Bulletin·L J Chapman, J P Chapman
Jun 1, 1973·Psychological Bulletin·L J Chapman, J P Chapman
Apr 11, 2001·Schizophrenia Research·J EdwardsR J Wales
Sep 30, 2003·The American Journal of Psychiatry·Christian G KohlerRuben C Gur
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·Melissa J Green, Mary L Phillips
May 9, 2006·Schizophrenia Research·Jean AddingtonDonald Addington
May 25, 2006·The British Journal of Clinical Psychology·Lloyd Humphreys, Christine Barrowclough
Nov 7, 2007·The Journal of Nervous and Mental Disease·Mascha Van't WoutRené S Kahn
Jan 5, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Jean AddingtonDiana O Perkins
Aug 1, 2008·Schizophrenia Bulletin·William P HoranMichael F Green
Feb 14, 2009·Cognitive Neuropsychiatry·Dennis R CombsDustin Chapman
Mar 31, 2009·Schizophrenia Bulletin·Christian G KohlerPaul J Moberg
Mar 20, 2010·Journal of the International Neuropsychological Society : JINS·Laura A Brown, Alex S Cohen
May 21, 2010·Psychiatry Research·Raymond C K ChanQi-Yong Gong
Jul 14, 2010·Neuroscience and Biobehavioral Reviews·Anne-Kathrin J FettLydia Krabbendam
Jul 29, 2010·Schizophrenia Research·Ute HabelThilo Kellermann
Nov 30, 2010·Schizophrenia Research·Amy E PinkhamRuben C Gur
Mar 23, 2011·Schizophrenia Bulletin·G Paul AmmingerPatrick D McGorry
Nov 2, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Graham C L Davey
Mar 1, 2012·Early Intervention in Psychiatry·Gavin R Abbott, Melissa J Green
Mar 4, 2014·Psychiatry Research·Christian G KohlerMonica E Calkins
Apr 28, 2016·Scandinavian Journal of Psychology·Stella G Giakoumaki
Apr 30, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Martin Jáni, Tomáš Kašpárek
Dec 16, 2018·Psychiatry Research·Katja KoelkebeckSeiko Minoshita
May 7, 2019·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Michael F GreenJunghee Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.